Clonidine extended-release was FDA approved in 2009 and guanfacine in 2010, both only for children and adolescents with ADHD, where they are typically considered second-line choices for patients who cannot tolerate stimulants or as adjunctive therapy to enhance stimulant effects.
factualpending
Speaker
Dr. Tracey MarksEvidence Quote
“Clonidine extended release was FDA approved in 2009, and guanfacine in 2010. They were only approved though for children and adolescents with ADHD”
Created: 8/11/2026, 5:26:50 AM
Your notes
Loading notes...